Go to AAD Home
Donate For Public and Patients Store Search

Go to AAD Home
Welcome!
Advertisement
Advertisement

Race for the Case


Race for the Case is a clinical quiz feature published quarterly in DermWorld Directions in Residency — and right here!

Answer the questions below to enter. Looking for the Spring 2026 answers? Review them now. To submit cases and questions, email Emily Margosian at emargosian@aad.org.


Diagnose this new case by Nancy Shen, MD

Race for the Case Summer 2026

A 61-year-old female with history of acute myeloid leukemia (AML) status-post unrelated donor stem cell transplant two months prior presented to the hospital with two weeks of an itchy rash that first appeared on her legs. The patient reported spread of the rash to her face, chest, and back over the past week, although denied blistering, burning, or pain at involved areas. On exam, there were erythematous patches and plaques with thin scale present over the chest, back, and upper and lower extremities, affecting approximately 40% of her body surface area. The patient did not have mucosal involvement and no bullae were present. The patient denied all other symptoms including fever, chills, dyspnea, abdominal pain, vomiting, diarrhea, and urinary changes. She also denied any recent changes in her medications preceding the rash.

Laboratory evaluation was remarkable for chronic thrombocytopenia. Urinalysis, bilirubin, and liver enzymes were normal. A 4-millimeter punch biopsy was obtained from the upper back and submitted for hematoxylin and eosin (H&E) staining. The biopsy returned with vacuolar interface dermatitis with mild perivascular infiltrate in the superficial dermis. Interface change with necrotic keratinocytes extended down epithelial adnexal structures.

  1. What are the three most common organs affected in graft-versus-host disease (GVHD)?

  2. What is the underlying immunologic cause of GVHD?

  3. What is the time cutoff between acute and chronic cutaneous GVHD?

  4. What stage and chronicity of skin GVHD does this patient meet?

  5. What is the first-line systemic treatment for this patient?

  6. What are four common cutaneous manifestations of chronic GVHD?


Fill out my online form.

Related Academy resources

Boards fodder

Download every Boards Fodder in PDF format.

DW Insights and Inquiries

Keep up with current dermatologic literature and how to use the information in practice.

Directions in Residency

Access the archive of Directions in Residency.

Advertisement
Advertisement
Advertisement